Ultragenyx Pharmaceutical Inc. Email & Phone number of top level executives

Ultragenyx Pharmaceutical Inc.

Healthcare, Pharmaceuticals, and Biotech

Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company focused on developing therapies to treat rare and ultra-rare genetic diseases. Founded in 2010, the company's mission is to bring life-changing treatments to patients with unmet medical needs. Ultragenyx has a diverse pipeline of drugs in various stages of development, including treatments for lysosomal storage disorders, muscle and liver disorders, and metabolic disorders. The company's flagship product Crysvita has been approved by the FDA for the treatment of X-linked hypophosphatemia, a rare genetic disorder. Ultragenyx is committed to advancing science and improving the lives of patients affected by rare diseases.